BioMark Diagnostics Inc. (BUX.CN)

CAD 0.2

(0.0%)

Total Debt Summary of BioMark Diagnostics Inc.

BioMark Diagnostics Inc.'s latest annual total debt in 2023 was 805.93 Thousand CAD , down -2.18% from previous year.
BioMark Diagnostics Inc.'s latest quarterly total debt in 2024 Q1 was 721.95 Thousand CAD , down -10.42% from previous quarter.
BioMark Diagnostics Inc. reported annual total debt of 823.87 Thousand CAD in 2022, down -21.49% from previous year.
BioMark Diagnostics Inc. reported annual total debt of 1.04 Million CAD in 2021, up 779.45% from previous year.
BioMark Diagnostics Inc. reported quarterly total debt of 805.93 Thousand CAD for 2023 Q4, down -18.06% from previous quarter.
BioMark Diagnostics Inc. reported quarterly total debt of 737.64 Thousand CAD for 2023 Q1, down -10.47% from previous quarter.

Annual Total Debt Chart of BioMark Diagnostics Inc. (2023 - 2013)

Historical Annual Total Debt of BioMark Diagnostics Inc. (2023 - 2013)

Year	Total Debt	Total Debt Growth
2023	805.93 Thousand CAD	-2.18%
2022	823.87 Thousand CAD	-21.49%
2021	1.04 Million CAD	779.45%
2020	119.32 Thousand CAD	1277.24%
2019	8664.00 CAD	0.0%
2018	- CAD	0.0%
2017	- CAD	0.0%
2016	- CAD	0.0%
2015	- CAD	0.0%
2014	- CAD	0.0%
2013	- CAD	0.0%

Year	Total Debt	Total Debt Growth
2024 Q1	721.95 Thousand CAD	-10.42%
2023 Q4	805.93 Thousand CAD	-18.06%
2023 Q1	737.64 Thousand CAD	-10.47%
2023 FY	805.93 Thousand CAD	-2.18%
2023 Q2	516.43 Thousand CAD	-29.99%
2023 Q3	983.56 Thousand CAD	90.45%
2022 Q4	823.87 Thousand CAD	-9.3%
2022 Q3	908.29 Thousand CAD	-8.37%
2022 Q2	991.24 Thousand CAD	1.1%
2022 Q1	980.49 Thousand CAD	-6.57%
2022 FY	823.87 Thousand CAD	-21.49%
2021 Q1	117.84 Thousand CAD	-1.24%
2021 Q2	116.36 Thousand CAD	-1.26%
2021 FY	1.04 Million CAD	779.45%
2021 Q3	969.82 Thousand CAD	733.47%
2021 Q4	1.04 Million CAD	8.2%
2020 Q3	100 Thousand CAD	23.06%
2020 Q4	119.32 Thousand CAD	19.32%
2020 Q1	5000.00 CAD	-42.29%
2020 Q2	81.26 Thousand CAD	1525.26%
2020 FY	119.32 Thousand CAD	1277.24%
2019 Q2	- CAD	0.0%
2019 Q1	- CAD	0.0%
2019 FY	8664.00 CAD	0.0%
2019 Q4	8664.00 CAD	-99.08%
2019 Q3	945.5 Thousand CAD	0.0%
2018 Q3	1 Million CAD	12.75%
2018 Q4	- CAD	-100.0%
2018 FY	- CAD	0.0%
2018 Q1	857.38 Thousand CAD	0.0%
2018 Q2	894.74 Thousand CAD	4.36%
2017 FY	- CAD	0.0%
2017 Q4	- CAD	-100.0%
2017 Q3	695.4 Thousand CAD	6.07%
2017 Q2	655.59 Thousand CAD	-16.29%
2017 Q1	783.16 Thousand CAD	0.0%
2016 Q1	425.62 Thousand CAD	0.0%
2016 FY	- CAD	0.0%
2016 Q2	551.88 Thousand CAD	29.66%
2016 Q4	- CAD	0.0%
2016 Q3	- CAD	-100.0%
2015 Q1	142.33 Thousand CAD	0.0%
2015 Q3	335.67 Thousand CAD	51.41%
2015 Q4	- CAD	-100.0%
2015 FY	- CAD	0.0%
2015 Q2	221.69 Thousand CAD	55.76%
2014 FY	- CAD	0.0%
2014 Q2	- CAD	0.0%
2014 Q3	114.09 Thousand CAD	0.0%
2014 Q4	- CAD	-100.0%
2014 Q1	- CAD	0.0%
2013 FY	- CAD	0.0%

Peer Total Debt Comparison of BioMark Diagnostics Inc.

Name	Total Debt	Total Debt Difference
Izotropic Corporation	2.05 Million CAD	60.808%
Sona Nanotech Inc.	527.68 Thousand CAD	-52.731%